![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
20
S.a.l.a.r.s. S.p.a. Como It, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Morphine hemisulfate 2.5-hydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2011-118 - Rev 02
This Chemical Type CEP, issued on May 27, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1244 associated with this CEP further emphasizes